Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DMP Spine is a healthcare company focused on spine and orthopedic products, operating primarily as a medical device and biologics distribution business rather than a therapeutic drug developer. Publicly available information links the name to DMP Spine Investments, DMP Spine Biologics, and DMP Spine Technologies, which appear to be related entities using the DMP Spine brand. The company has been described as designing, manufacturing, and distributing products for neurology and spine surgical professionals, with a particular emphasis on bringing U.S.-based products into European markets. DMP Spine is best documented through its commercial partnership with Bacterin International Holdings to distribute bone graft and related biologic products in the European Union. Available evidence suggests a commercial-stage medtech business with limited publicly disclosed pipeline detail.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DMP Spine.